Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy H Peterman

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Epidemiology|October 27, 2004
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleDavid T Eton, David Cella, Kathleen J Yost, et al.
Journal of General Internal Medicine|November 7, 2006
Religion, spirituality, and depressive symptoms in patients with HIV/AIDSMichael S Yi, Joseph M Mrus, Terrance J Wade, et al.
Psycho-Oncology|March 6, 2024
"Pathways": A hope-enhancing intervention for patients undergoing treatment for advanced lung cancerLaurie E McLouth, Brent J Shelton, Vilma Bursac, et al.
Journal of General Internal Medicine|November 7, 2006
Spirituality and religion in patients with HIV/AIDSSian Cotton, Christina M Puchalski, Susan N Sherman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2007
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapyZeeshan Butt, Lynne I Wagner, Jennifer L Beaumont, et al.
Journal of Pain and Symptom Management|October 26, 2007
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practiceZeeshan Butt, Lynne I Wagner, Jennifer L Beaumont, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancerThomas E Stinchcombe, Amy H Peterman, Carrie B Lee, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Clinical Epidemiology|October 27, 2004
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scaleDavid T Eton, David Cella, Kathleen J Yost, et al.
Journal of General Internal Medicine|November 7, 2006
Religion, spirituality, and depressive symptoms in patients with HIV/AIDSMichael S Yi, Joseph M Mrus, Terrance J Wade, et al.
Psycho-Oncology|March 6, 2024
"Pathways": A hope-enhancing intervention for patients undergoing treatment for advanced lung cancerLaurie E McLouth, Brent J Shelton, Vilma Bursac, et al.
Journal of General Internal Medicine|November 7, 2006
Spirituality and religion in patients with HIV/AIDSSian Cotton, Christina M Puchalski, Susan N Sherman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 5, 2007
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapyZeeshan Butt, Lynne I Wagner, Jennifer L Beaumont, et al.
Journal of Pain and Symptom Management|October 26, 2007
Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practiceZeeshan Butt, Lynne I Wagner, Jennifer L Beaumont, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 1, 2011
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancerThomas E Stinchcombe, Amy H Peterman, Carrie B Lee, et al.
Pageof 3